Next Article in Journal
Biological Variability and Impact of Oral Contraceptives on Vitamins B6, B12 and Folate Status in Women of Reproductive Age
Previous Article in Journal
Vitamin D: Deficiency, Sufficiency and Toxicity
Open AccessArticle

Fatty Acid and Phytosterol Content of Commercial Saw Palmetto Supplements

Department of Human Nutrition, Kansas State University, Manhattan, KS 66506, USA
*
Author to whom correspondence should be addressed.
Nutrients 2013, 5(9), 3617-3633; https://doi.org/10.3390/nu5093617
Received: 13 June 2013 / Revised: 16 August 2013 / Accepted: 20 August 2013 / Published: 13 September 2013
Saw palmetto supplements are one of the most commonly consumed supplements by men with prostate cancer and/or benign prostatic hyperplasia (BPH). Some studies have found significant improvements in BPH and lower urinary tract symptoms (LUTS) with saw palmetto supplementation, whereas others found no benefits. The variation in the efficacy in these trials may be a result of differences in the putative active components, fatty acids and phytosterols, of the saw palmetto supplements. To this end, we quantified the major fatty acids (laurate, myristate, palmitate, stearate, oleate, linoleate) and phytosterols (campesterol, stigmasterol, β-sitosterol) in 20 commercially available saw palmetto supplements using GC-FID and GC-MS, respectively. Samples were classified into liquids, powders, dried berries, and tinctures. Liquid saw palmetto supplements contained significantly higher (p < 0.05) concentrations of total fatty acids (908.5 mg/g), individual fatty acids, total phytosterols (2.04 mg/g), and individual phytosterols, than the other supplement categories. Powders contained significantly higher (p < 0.05) concentrations of total fatty acids than tinctures, which contain negligible amounts of fatty acids (46.3 mg/g) and phytosterols (0.10 mg/g). Our findings suggest that liquid saw palmetto supplements may be the best choice for individuals who want to take a saw palmetto supplement with the highest concentrations of both fatty acids and phytosterols. View Full-Text
Keywords: saw palmetto; serenoa repens; prostate; benign prostatic hyperplasia; prostate cancer; fatty acids; phytosterols; supplements saw palmetto; serenoa repens; prostate; benign prostatic hyperplasia; prostate cancer; fatty acids; phytosterols; supplements
Show Figures

Graphical abstract

MDPI and ACS Style

Penugonda, K.; Lindshield, B.L. Fatty Acid and Phytosterol Content of Commercial Saw Palmetto Supplements. Nutrients 2013, 5, 3617-3633. https://doi.org/10.3390/nu5093617

AMA Style

Penugonda K, Lindshield BL. Fatty Acid and Phytosterol Content of Commercial Saw Palmetto Supplements. Nutrients. 2013; 5(9):3617-3633. https://doi.org/10.3390/nu5093617

Chicago/Turabian Style

Penugonda, Kavitha; Lindshield, Brian L. 2013. "Fatty Acid and Phytosterol Content of Commercial Saw Palmetto Supplements" Nutrients 5, no. 9: 3617-3633. https://doi.org/10.3390/nu5093617

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop